Ind-Swift Ltd
| Small Cap
Ind-Swift Ltd, operating within the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency and profitability, driven by its debt management and margins. However, it struggles with liquidity, efficiency, and growth, indicating potential challenges in short-term obligations, asset utilization, and expansion. While the company exhibits reasonable financial health overall, these inconsistencies suggest areas needing attention to ensure sustainable performance. The company's ability to meet its obligations and manage its resources efficiently will be critical for future stability and growth. The weighted average calculation method ensures that recent performance has a greater impact on the overall assessment.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio2.00
- Financial Ratio2.40
- Profitability Ratio7.80
- Efficiency Ratio4.00
- Coverage Ratio2.00
- Solvency Ratio8.60
- Liquidity Ratio2.40
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthNeutral
Ind-Swift Ltd, operating within the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency and profitability, driven by its debt management and margins. However, it struggles with liquidity, efficiency, and growth, indicating potential challenges in short-term obligations, asset utilization, and expansion. While the company exhibits reasonable financial health overall, these inconsistencies suggest areas needing attention to ensure sustainable performance. The company's ability to meet its obligations and manage its resources efficiently will be critical for future stability and growth. The weighted average calculation method ensures that recent performance has a greater impact on the overall assessment.
Overall Valuation Score
P/E RATIO (TTM)
0.32
Industry Median
33.32
Small Cap Median
30.63
P/E RATIO
0.32
P/B RATIO
0.00
Industry Median
3.85
Small Cap Median
3.32
P/S RATIO
N/A
Industry Median
228.59
Small Cap Median
199.39
Others
PEG RATIO
0.00
EV/EBITDA RATIO
2.43
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The growth ratios indicate significant challenges in expanding revenue, profitability, and assets. Negative growth rates across multiple metrics suggest potential issues with market demand, operational efficiency, or strategic investments. Addressing these challenges is crucial for ensuring the company's long-term sustainability and competitive positioning within the healthcare sector.
| Growth Ratios | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 2.66 | 47.41 | 3.27 | 22.14 | 2.59 |
| Operating Profit Growth Rate | -112.31 | 462.5 | -6.67 | 28.57 | -57.41 |
| Earnings Per Share (EPS) Growth | -86.47 | -60.26 | -230 | -45.32 | 1889.73 |
| Asset Growth Rate | -7.52 | 2.76 | 2.69 | 0.77 | 11.31 |
| Net Income Growth Rate | -86.6 | -60 | -230 | -46.15 | 1921.43 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial metrics present a mixed financial performance. Negative adjusted earnings per share and book value per share are concerning, while the low capital expenditure may limit future growth opportunities. Improving profitability and managing capital investments are essential to improve financial health.
| Financial Ratios | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | -9.09 | -3.64 | 4.73 | 2.55 | 51.45 |
| Cash Earnings Per Share (Cash EPS) | -2.73 | 2.18 | 10 | 7.45 | 55.82 |
| Book Value Per Share | -123.09 | -130.91 | -128.18 | -125.64 | -73.09 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 6.2 | 19.6 | 30.8 | 28.5 | 40.7 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The profitability metrics reflect a strong performance driven by operating margins, return on capital employed and gross profit margin. However, return on assets and a negative return on equity need to be improved. Consistent profitability is essential for sustaining long-term growth and shareholder value within the competitive healthcare industry.
| Profitability Ratios | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Gross Profit Margin | -10 | 3.27 | 3.16 | 5.38 | -0.19 |
| Return on Capital Employed (ROCE) | -4.34 | 3.96 | 12.45 | 5.93 | 25.08 |
| Return on Equity (ROE) | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (ROA) | 1.3 | 7.12 | 6.47 | 8.26 | 3.16 |
| Operating Margin | 2.96 | 11.31 | 10.22 | 10.76 | 4.47 |
| Net Margin | -18.52 | -5.03 | 6.33 | 2.79 | 54.95 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency metrics present a mixed picture. While the days sales in inventory ratio is excellent, the fixed asset, inventory, and receivables turnover ratios are low, suggesting inefficient asset utilization. This could result in higher holding costs and slower conversion of assets into revenue. Improving these ratios could significantly enhance the company's operational performance and profitability.
| Efficiency Ratios | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 0.87 | 1.69 | 1.9 | 2.73 | 2.12 |
| Inventory Turnover Ratio | 7.07 | 6.68 | 5.01 | 6.21 | 6.04 |
| Receivables Turnover Ratio | 2.81 | 4.55 | 4.19 | 3.91 | 3.31 |
| Days Sales in Inventory Ratio | 51.63 | 54.64 | 72.85 | 58.78 | 60.43 |
| Receivable Days | 129.89 | 80.22 | 87.11 | 93.35 | 110.27 |
| Capital Turnover Ratio | 0.25 | 0.43 | 0.59 | 0.38 | 0.39 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The coverage ratios suggest a limited ability to meet interest obligations and provide dividends to equity holders. Low interest coverage indicates a higher risk of financial distress, while the absence of equity dividend coverage may deter potential investors. Improving profitability and cash flow is essential for enhancing these coverage ratios.
| Coverage Ratios | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Interest Coverage Ratio | -21.69 | -6.57 | 0.65 | 1.43 | 1.25 | 8.38 |
| Equity Dividend Coverage Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The solvency position reflects a strong financial structure. Negative debt-to-equity ratio and high debt ratios suggest that the company relies more on equity than debt financing. This conservative approach reduces the risk of financial distress and provides a stable base for long-term growth. The healthcare industry often benefits from stable funding sources due to the essential nature of its services.
| Solvency Ratios | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debt Ratio | 38.61 | -7.28 | -1.45 | 3.08 | 1.93 |
| Debt to Equity Ratio | -1.03 | -0.88 | -0.59 | -1.48 | -2.08 |
| Equity Ratio | -37.61 | 8.28 | 2.45 | -2.08 | -0.93 |
| Debt To Asset Ratio | 1.13 | 1 | 0.64 | 1.57 | 1.14 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The liquidity position suggests challenges in meeting immediate obligations. While the operating cash flow ratio shows some ability to cover current liabilities with operational cash, the other ratios indicate potential difficulties in converting assets into cash quickly. This situation could restrict the company's financial flexibility and ability to respond to unforeseen expenses or investment opportunities. The healthcare industry's unique working capital requirements may exacerbate these liquidity concerns.
| Liquidity Ratios | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Current Ratio | 0.42 | 0.44 | 0.37 | 1.25 | 1.61 |
| Quick Ratio | 0.35 | 0.35 | 0.27 | 1.06 | 1.25 |
| Cash Ratio | 0.01 | 0.02 | 0.01 | 0.19 | 0.23 |
| Operating Cash Flow Ratio | 0.01 | 0.07 | 0.08 | 0.04 | 0.05 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Sangani Hospitals Ltd | 7.21 | 20.32 | Neutral | 8.00 | 1.74 | 4.00 |
| 2 | Zenith Drugs Ltd | 4.63 | 7.52 | Neutral | 17.00 | 2.30 | 10.00 |
| 3 | Mohini Health & Hygiene Ltd | 4.51 | -3.19 | Neutral | -3.00 | -8.32 | -17.00 |
| 4 | Ind-Swift Ltd | 3.76 | 0.32 | Neutral | 23.00 | 52.33 | 283.00 |
The management of Ind-Swift Ltd demonstrates a mixed performance. While there are positive signs of improved profitability and sales growth, significant financial challenges such as high debt and negative book value persist. The stable promoter holding indicates sustained confidence from within. However, the absence of institutional investment and inconsistent operational performance raise concerns. Overall, management effectiveness is rated as mixed due to the combination of turnaround efforts and existing financial vulnerabilities.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Profit Growth (TTM) | 309% | Indicates a strong recent improvement in earnings |
| Promoter Holding | 55.58% | Reflects stable confidence from within | |
| CONS | Total Borrowings (Sep 2024) | ₹ 1,023 Cr. | High debt levels pose financial risk |
| Book Value | Negative | Raises concerns about long-term solvency |
Financial Performance & Growth
Ind-Swift Ltd.'s financial performance presents a fluctuating trend. Sales Growth has been erratic, with a TTM of 7%. Quarterly sales have varied significantly, with YOY Sales Growth % fluctuating between -23.35% and 56.90%. OPM % also shows considerable variation, ranging from 2.83% (Jun 2024) to 16.79% (Dec 2022). Profit Growth shows a TTM of 309%. The inconsistency in sales and OPM, along with reliance on other income, raises concerns about sustainable profitability.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Sales Growth (%) | N/A | 3.33% | 22.21% |
| OPM (%) | 11% | 10% | 11% |
Capital Efficiency & Returns
The Return on Capital Employed (ROCE) for Ind-Swift Ltd. has shown improvement. The ROCE % for March 2023 was 8%, increasing to 13% in March 2024. The Cash Conversion Cycle has been consistently negative, with a value of -68 days in March 2024, suggesting efficient working capital management.
| Metric | 2023 | 2024 |
|---|---|---|
| ROCE (%) | 8% | 13% |
| Cash Conversion Cycle | -150 | -68 |
Financial Health & Prudence
Ind-Swift Ltd. faces challenges in its financial health, primarily related to debt management. The company's borrowings remain high, with total borrowings at ₹ 1,023 Cr. as of September 2024. Dividend payout is consistently at 0%. The company's high debt levels and negative book value pose risks to long-term financial stability.
| Metric | 2016 | 2017 | 2018 | 2022 | 2023 | 2024 | 2024 (Sep) |
|---|---|---|---|---|---|---|---|
| Borrowings | 1061 | 1062 | 1055 | 1036 | 993 | 1014 | 1023 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | N/A |
Shareholding & Ownership Structure
The promoter holding in Ind-Swift Ltd. is stable at 55.58% from June 2022 to March 2025. The number of shareholders has increased from 14,296 in June 2022 to 21,368 in March 2025.
| Metric | Jun 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Promoter Holding (%) | 55.58% | 55.58% | 55.58% | 55.58% |
| Shareholders | 14,296 | 14,785 | 16,438 | 21,368 |
Ind-Swift Ltd. exhibits a moderate risk profile due to high debt levels and negative book value, raising concerns about financial stability. The company has contingent liabilities. These factors necessitate careful financial management to mitigate potential adverse effects.
Contingent liability evaluation
The company has contingent liabilities, indicating potential future obligations that could affect its financial stability. These liabilities can create uncertainty and pose a risk to the company's solvency if they materialize.
Foreign exchange or interest rate exposure
There is no specific data available on foreign exchange or interest rate exposure.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe